Alnylam Pharmaceuticals, Inc. is a biopharmaceutical company. The Company is engaged in the discovery, development and commercialization of ribonucleic acid (RNA) interference (RNAi) therapeutics. The Company is focused on the use of its N-acetylgala... Read more
MarketWatch
CNBC
CNBC
CNBC
Access detailed stock analysis from LSEG including analyst price target estimates.